CSIMarket Company Name, Ticker, Customers, else..
 
• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Nemaura Medical Inc   (NMRD)
Other Ticker:  
 

Nemaura Medical Inc 's Working Capital Per Sales

NMRD's Working Capital and Revenue growth



NMRD Working Capital Per Revenue (Dec 31 2023)
III. Quarter		 (Sep 30 2023)
II. Quarter		 (Jun 30 2023)
I. Quarter		 (Mar 31 2023)
IV. Quarter		 (Dec 31 2022)
III. Quarter
Y / Y Working Capital Change - - - - -
Y / Y Revenue Change - - - - -98.36 %
Working Capital Per Revenue - - - - -
Total Ranking # # # # #
Seq. Working Capital Change - - - - -
Seq. Revenue Change - - - - -95.92 %


New: More NMRD's historic Working Capital Per Revenue Ratios >>


Financial strength information for the Healthcare sector >> Back to NMRD Financial Strength Comparisons >> See NMRD Balance Sheets

Comment on NMRD's Working Capital Per Revenue in the third quarter 2023
Nemaura Medical Inc 's Working Capital Per Revenue sequentially grew to 7.18 during the Q3 2023, above the company average. Due to increase of revenue in the Q3 2023 year on year by -100%.

Within Healthcare sector Nemaura Medical Inc has achieved the lowest Working Capital Per Revenue. While Working Capital Per Revenue remained unchanged in the Q3 2023 relative to the prior quarter at no. .
Working Capital Per Revenue Ranking
Within: No.
Industry #
Sector #
S&P 500 #


Working Capital Per Revenue Statistics
High Average Low
0
0
0
 



Financial Statements
Nemaura Medical Inc 's Working Capital $ -17 Millions Visit NMRD's Balance sheet
Nemaura Medical Inc 's Revenues $ 0 Millions Visit NMRD's Income Statement
Where are NMRD's Sales coming from? Visit NMRD's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Dec 31 2023, within Healthcare Sector Working Capital Per Revenue
Vir Biotechnology Inc   19.18 
Inovio Pharmaceuticals Inc   15.94 
Bicycle Therapeutics Plc  15.66 
Galapagos Nv  14.32 
Helius Medical Technologies inc   12.76 
Xoma Corporation  12.63 
Ainos Inc   12.59 
Femasys Inc   11.36 
Catheter Precision Inc   11.09 
C4 Therapeutics Inc   10.68 
Co diagnostics Inc   10.46 
Dbv Technologies S a   9.52 
Delcath Systems Inc   9.30 
Caribou Biosciences Inc   7.85 
Recursion Pharmaceuticals Inc   7.73 
Ac Immune Sa  7.54 
Abeona Therapeutics Inc   7.17 
Aeterna Zentaris Inc   7.08 
Affimed N v   7.04 
Prothena Corporation Public Limited Company  6.78 
Lipella Pharmaceuticals Inc   6.67 
Vaxart Inc   6.61 
Foghorn Therapeutics Inc   6.54 
Werewolf Therapeutics Inc   6.41 
Arcus Biosciences Inc   6.35 
Carisma Therapeutics Inc   6.31 
Predictive Oncology Inc   6.12 
Inspiremd Inc   5.95 
Curis Inc   5.87 
Innovative Eyewear Inc   5.32 
Date modified: 2024-02-12T17:09:11+00:00



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com